DanielRicardoCourielMD

Oncology • Salt Lake City, UT

Hematologic Oncology

Professor, Internal Medicine, University of Michigan Medical School

Join to view full profile

Dr. Couriel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Couriel's full profile

Already have an account?

Office
2000 Circle of Hope Dr
Ofc 2151
Salt Lake City, UT 84112
Phone+1 801-213-2082

Education & Training

George Washington UniversityResidency, Internal Medicine, 1995 - 1997
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1993 - 1995
St Elizabeth's Medical CenterFellowship, Hematology and Medical Oncology, 1991 - 1993
University of Buenos AiresClass of 1987

Certifications & Licensure

ID State Medical License 2017 - 2026
UT State Medical License 2015 - 2026
CO State Medical License 2016 - 2025
MI State Medical License 2010 - 2017
TN State Medical License 2007 - 2011
TX State Medical License 2000 - 2009
AL State Medical License 1997 - 1999
MD State Medical License 1995 - 1998
American Board of Internal Medicine Hematology
Join now to see all

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Trial Of Double Umbilical Cord Blood Transplantation Start of enrollment: 2008 Dec 01
Completed
Phase 2
Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 Start of enrollment: 2010 Oct 01
Active, not recruiting
Phase 3
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
Recruiting
Scleroderma Treatment With Autologous Transplant (STAT) Study Start of enrollment: 2011 Sep 15
Active, not recruiting
Phase 2
Double Cord Versus Haploidentical (BMT CTN 1101) Start of enrollment: 2012 Jun 01
Completed
Phase 3
The PUMA Trial is a Trial of a Single ProHema Modulated-Cord Blood (CB) Unit as Part of a Double CB Transplant in Patients With Hematologic Malignancies. Start of enrollment: 2012 Jul 01
Terminated
Phase 2
Join now to see all

Publications & Presentations

PubMed

26 citations
Sarcopenia is associated with autologous transplant-related outcomes in patients with lymphoma
Megan E.V. Caram, Emily Bellile, Michael J. Englesbe, Michael N. Terjimanian, Stewart C. Wang
Leukemia & Lymphoma. 2015-03-05
3 citations
Access to CAR T-cell therapy: Focus on diversity, equity and inclusion.
Maria S Odstrcil, Catherine J Lee, Catherine Sobieski, Daniel Weisdorf, Daniel Couriel
Blood Reviews. 2024-01-01
238 citations
Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide...
Issa F. Khouri, Peter McLaughlin, Rima M. Saliba, Chitra Hosing, Martin Korbling
Blood. 2008-06-15

Press Mentions

Cutting Edge Advancements in Regenerative Medicine Takes Centerstage at 2nd Annual ADSCC Bone Marrow Transplant & Cellular Therapy Congress 2024October 28th, 2024
Hospital Offering Some Cancer Trials Through HuntsmanJune 20th, 2017

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Other Languages

Spanish, French